Skip to content
Menu

Coherus Oncology, Inc. CHRS

Full chart Compare
Set alert

Price alert · CHRS

All alert types
0.37 USD -0.02 (-4.47%)

Regular-session close

0.37 0.00 +0.59%

After hours · Nov 20, 6:09 PM ET

0.3628 Day range 0.4084
0.3628 52-week range 2.62
YTD
-73.96%
1 year
-66.38%

CHRS revenue history

Revenue is income from the company’s ordinary business activities.

42,172,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Scroll the table to see all values →

Revenue · annual · USD
Fiscal periodPeriod endRevenueYoY changeYoY %
FY 20252025-12-3142,172,00015,783,00059.81%
FY 20242024-12-3126,389,000-230,855,000-89.74%
FY 20232023-12-31257,244,00046,202,00021.89%
FY 20222022-12-31211,042,000-115,509,000-35.37%
FY 20212021-12-31326,551,000-149,273,000-31.37%
FY 20202020-12-31475,824,000119,753,00033.63%
FY 20192019-12-31356,071,000356,071,000Not meaningful
FY 20182018-12-310-1,556,000-100.00%
FY 20172017-12-311,556,000-188,550,000-99.18%
FY 20162016-12-31190,106,000160,065,000532.82%
FY 20152015-12-3130,041,000-1,065,000-3.42%
FY 20142014-12-3131,106,00028,355,0001030.72%
FY 20132013-12-312,751,000852,00044.87%
FY 20122012-12-311,899,000Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-08-07T06:00:49.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.